Disclosures: Cara Mack: Nothing to Disclose, Alexander Miethke: Mirum Pharmaceutical Inc: Grant/Research Support, Mirum Pharmaceutical Inc: Consultant, Ipsen: Speaking and Teaching, Kieran Hawthorne: Nothing to Disclose, Lisa Henn: Murata Vios: Consultant, Simon Horslen: Nothing to Disclose, Shika Sundaram: Nothing to Disclose, Estella Alonso: Nothing to Disclose, Nitika Gupta: Nothing to Disclose, Binita Kamath: Mirum: Consultant, Mirum: Grant/Research Support, Albireo/Ipsen: Consultant, Albireo/Ipsen: Grant/Research Support, Audentes: Consultant 2353 OBETICHOLIC ACID FOR PRIMARY BILIARY CHOLANGITIS IN THE PREVENTION OF CLINICAL EVENTS: A MODELING STUDY USING REAL-WORLD DATA Zobair Younossi 1 Alexandra Ellis 2 Jackie Lee 3 Leona Bessonova 4 Radhika Nair 4 Elizabeth Potente 4 Robert Gish 5 , 1 The Global Liver Council, Center for Outcomes Research in Liver Disease, Washington, DC, USA, 2 Stratevi, Boston, Massachusetts, USA, 3 Stratevi, Santa Monica, California, USA, 4 Intercept Pharmaceuticals, Morristown, New Jersey, USA, 5 Robert G
3 Drugs to Treat the Motor Symptoms of PD The modern era of pharmacological treatments for the motor symptoms of PD started with the pioneering discoveries of the antagonizing effects of levodopa on the akinesia induced by reserpine in rabbits by the Swedish pharmacologist Arvid Carlsson [10] and of dopamine depletion in the striatum of brains from PD patients by the Austrian pharmacologist Oleh Hornykiewicz, who together with the neurologist Birkmayer also reported on the striking effects of small doses of intravenous levodopa on PD motor symptoms [11]
Ingredients: CLA (Conjugated Linoleic Acid), Green Tea Extract (Camellia sinensis)[55% EGCG] (of which EGCG) Recommended use: Take a single serving of the product - 3 capsules with 300 ml of water
It's a transient signal that kicks off profound biological processes
